Reversed-phase liquid chromatographic determination of idarubicin and its 13-hydroxy metabolite in human plasma (Q69652613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2745632%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

title

Reversed-phase liquid chromatographic determination of idarubicin and its 13-hydroxy metabolite in human plasma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2745632%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

author name string

S Eksborg

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2745632%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

B Nilsson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2745632%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

publication date

1 March 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2745632%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

volume

488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2745632%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2745632%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

page(s)

427-434

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2745632%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic activity of 4-demethoxydauno-rubicin (idarubicin) in adult acute leukemia.

4 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

Method for the determination of 4-demethoxydaunorubicin, its quinone and hydroquinone metabolites in human plasma and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

Liquid chromatography in anticancer drug research with special reference to anthraquinone glycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

Extraction of daunorubicin and doxorubicin and their hydroxyl metabolites: self-association in aqueous solution

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982966-7

7 January 2021

10.1016/S0378-4347(00)82966-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2745632%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

1 reference